Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors under investigation for obesity, metabolic syndrome, energy expenditure, and cardiovascular risk factor research.
| Molecular Weight | 4723.45 g/mol |
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
This product is intended solely for laboratory and scientific research purposes. It is not intended for human or animal consumption, cosmetic application, or any therapeutic use. By purchasing this product, you confirm that you are a qualified researcher and that this product will be used exclusively in a controlled research environment in compliance with all applicable local laws and regulations.